A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects
A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects
This study is designed to compare the pharmacokinetics of three different formulations of
 Pf-04937319
Inclusion Criteria:

 -  Healthy male and/or female subjects between the ages of 21 and 55 years, inclusive.
 Healthy is defined as no clinically relevant abnormalities identified by a detailed
 medical history, full physical examination, including blood pressure and pulse rate
 measurement, 12-lead ECG or clinical laboratory tests.

 -  Subjects of childbearing potential must agree to use a highly effective method of
 contraception throughout the study and for at least 28-days after the last dose of
 treatment.

 -  Body Mass Index (BMI) of 23 to 33 kg/m2 and a total body weight >=50 kg (110 lbs).

 Exclusion Criteria:

 -  Evidence or history of clinically significant hematological, renal, endocrine,
 pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
 allergic disease (excluding untreated seasonal allergies).

 -  Any condition possibly affecting drug absorption (eg, gastrectomy).

 -  A positive urine drug screen.